Drug candidate for reversing mucosal barrier damage by HIV

Investigators tested a laboratory-made version of a naturally occurring protein (recombinant fragment of human Surfactant Protein D or rfhSP-D) on bioengineered vaginal tissues, immune cells and microbes to determine if the drug candidate could help prevent HIV transmission safely.


Click here for original story, Drug candidate for reversing mucosal barrier damage by HIV


Source: ScienceDaily